CVS Health (NYSE: CVS) has defied the odds and is up over 50% year-to-date, whereas the broader market has corrected ...

CVS Health (CVS) closed the most recent trading day at $68.54, moving -0.55% from the previous trading session. This move was narrower than the S&P 500's daily loss of 2.24%. Meanwhile, the Dow ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...

The stock outperformed the S&P 500 ... The investment community will be closely monitoring the performance of CVS Health in its forthcoming earnings report. The company is scheduled to release ...

She most recently served as chief physician executive of healthcare performance improvement ... After today's rebound, CVS Health stock is up more than 50% year to date. Is the stock a buy?

One quarter into 2025, CVS Health (CVS) has gained the most of any stock in the S&P 500, with a share price that has popped 50% since the start of the year. Much of CVS’s gains came leading up ...

CVS Health’s CVS stock has gained strong momentum so far ... of margin recovery in 2025 compared to its current baseline performance. This will be the first stage in a three to four-year journey ...

NYSE:CVS Earnings and Revenue Growth March ... analyst recommendations to get a deeper understand of a stock's expected performance. There are plenty of analysts covering the stock, so it might ...

responsible for the operational performance across CVS Caremark, CVS Pharmacy, and the company's Healthcare Delivery ...